AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-25.15%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.37B
AUM Growth
+$2.37B
(-30%)
Cap. Flow
-$36.4M
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
48.11%
Holding
156
New
7
Increased
9
Reduced
11
Closed
16
Top Buys
| 1 |
argenx
ARGX
|
$27.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$21.6M |
| 3 |
IGMS
IGM Biosciences
IGMS
|
$13.4M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$10.2M |
| 5 |
VIGL
Vigil Neuroscience
VIGL
|
$7.88M |
Top Sells
| 1 |
Amicus Therapeutics
FOLD
|
$18.9M |
| 2 |
NovaGold Resources
NG
|
$17.8M |
| 3 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$14M |
| 4 |
Krystal Biotech
KRYS
|
$13.3M |
| 5 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$11.9M |
Sector Composition
| 1 | Healthcare | 91.85% |
| 2 | Consumer Discretionary | 6.7% |
| 3 | Financials | 0.57% |
| 4 | Consumer Staples | 0.32% |
| 5 | Industrials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
argenx
ARGX
$43.6B
| $185M | 7.76% | 587,500 +87,500 | +18% | +$27.6M |
|
|
WW
2
DELISTED
WW International
WW
| $152M | 6.35% | 14,818,300 | – | – |
|
3
Lexicon Pharmaceuticals
LXRX
$400M
| $149M | 6.23% | 71,178,364 | – | – |
|
|
ONC
4
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $125M | 5.25% | 665,000 -10,000 | -1% | -$1.89M |
|
|
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $111M | 4.65% | 1,350,000 -50,000 | -4% | -$4.11M |
|
6
Alnylam Pharmaceuticals
ALNY
$58.5B
| $106M | 4.44% | 650,000 | – | – |
|
|
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
| $93.6M | 3.92% | 650,000 +150,000 | +30% | +$21.6M |
|
8
Fate Therapeutics
FATE
$120M
| $77.5M | 3.25% | 2,000,000 +200,000 | +11% | +$7.75M |
|
9
Seer Inc
SEER
$115M
| $72.4M | 3.03% | 4,750,000 | – | – |
|
|
MORF
10
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $66.2M | 2.77% | 1,650,000 +64,951 | +4% | +$2.61M |
|
|
BLU
11
DELISTED
BELLUS Health Inc.
BLU
| $58.5M | 2.45% | 8,500,000 | – | – |
|
|
IGMS
12
DELISTED
IGM Biosciences
IGMS
| $53.5M | 2.24% | 2,000,000 +500,000 | +33% | +$13.4M |
|
|
CERE
13
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $52.5M | 2.2% | 1,500,000 | – | – |
|
|
SWTX
14
DELISTED
SpringWorks Therapeutics
SWTX
| $48M | 2.01% | 850,000 | – | – |
|
15
Kymera Therapeutics
KYMR
$2.95B
| $42.3M | 1.77% | 1,000,000 | – | – |
|
|
16
Amicus Therapeutics
FOLD
$2.34B
| $37.9M | 1.59% | 4,000,000 -2,000,000 | -33% | -$18.9M |
|
17
Cytokinetics
CYTK
$4.23B
| $36.8M | 1.54% | 1,000,000 | – | – |
|
|
18
Krystal Biotech
KRYS
$4.27B
| $33.3M | 1.39% | 500,000 -200,000 | -29% | -$13.3M |
|
19
Scholar Rock
SRRK
$3.14B
| $31.6M | 1.32% | 2,450,000 | – | – |
|
20
Erasca
ERAS
$445M
| $27.3M | 1.14% | 3,172,221 | – | – |
|
21
Foghorn Therapeutics
FHTX
$286M
| $26.2M | 1.1% | 1,720,720 | – | – |
|
|
SAGE
22
DELISTED
Sage Therapeutics
SAGE
| $24.8M | 1.04% | 750,000 -250,000 | -25% | -$8.28M |
|
23
Schrodinger
SDGR
$1.44B
| $23.9M | 1% | 700,000 | – | – |
|
24
Relay Therapeutics
RLAY
$619M
| $21M | 0.88% | 700,000 -50,000 | -7% | -$1.5M |
|
25
Generation Bio
GBIO
$40.4M
| $20.7M | 0.86% | 2,814,191 | – | – |
|